Fingerprint
Dive into the research topics of 'Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically